Cargando…
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy that affects multiple systems including the muscle and heart. The mutant CTG expansion at the 3′-UTR of the DMPK gene causes the expression of toxic RNA that aggregate as nuclear foci. The foci then interfere with RNA-binding prot...
Autores principales: | Liu, Jie, Guo, Zhen-Ni, Yan, Xiu-Li, Yang, Yi, Huang, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634727/ https://www.ncbi.nlm.nih.gov/pubmed/34867280 http://dx.doi.org/10.3389/fnagi.2021.755392 |
Ejemplares similares
-
Altered Local Brain Amplitude of Fluctuations in Patients With Myotonic Dystrophy Type 1
por: Huang, Pei, et al.
Publicado: (2021) -
Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
por: López-Morató, Marta, et al.
Publicado: (2018) -
Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
por: Timchenko, Lubov
Publicado: (2022) -
Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017) -
Increased functional connectivity of white-matter in myotonic dystrophy type 1
por: Li, Jing, et al.
Publicado: (2022)